Antibody guided radioimmunotherapy - sigma-tau

Drug Profile

Antibody guided radioimmunotherapy - sigma-tau

Alternative Names: PAGRIT; Pre-targeted antibody guided radioimmunotherapy

Latest Information Update: 25 Jul 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator sigma-tau SpA
  • Class Antibodies; Radiopharmaceuticals
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Glioma; Non-Hodgkin's lymphoma

Most Recent Events

  • 25 Jul 2013 No development reported - Phase-I for Glioma in Italy (Parenteral)
  • 25 Jul 2013 No development reported - Phase-I for Non-Hodgkin's lymphoma in Italy (Parenteral)
  • 31 Dec 2009 Phase-I clinical trials in Glioma in Italy (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top